Summary:
Click image to enlarge
This trial is a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.
Be 65 - 90 years old; Diagnosed with Alzheimer's disease; Exhibiting restless, aggressive or irritable behaviors; Must live at home
*Other criteria apply
Qualified Participants May Receive:
- Alzheimer's agitation assessment at no cost
- Compensation Provided